Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 61
15
Diseases
18
Unique genes
0.295
Avg. similarity score
Dilated cardiomyopathy 1E
Most-connected disease (10 links)
Disease
Searched: Heart block, progressive, type ia
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Heart block, progressive, type ia
Dilated cardiomyopathy 1E
Heart block, nonprogressive
Progressive familial heart block 1a
Ectopic rhythm
Atrial standstill
Cardiac rhythm disease
Paroxysmal tachycardia
Paroxysmal ventricular fibrillation
Sudden infant death syndrome
Torsades de pointes
Hypercapnia
Intellectual developmental disorder, autosomal dominant 33
Neurodevelopmental disorder with cerebellar ataxia and movement disorders
Primary ciliary dyskinesia 5
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Dilated cardiomyopathy 1E | 10 | 10 | 1 |
| Heart block, nonprogressive | 10 | 10 | 1 |
| Heart block, progressive, type ia | 10 | 10 | 1 |
| Progressive familial heart block 1a | 9 | 9 | 1 |
| Ectopic rhythm | 6 | 6 | 2 |
| Atrial standstill | 5 | 5 | 3 |
| Cardiac rhythm disease | 5 | 5 | 2 |
| Paroxysmal tachycardia | 5 | 5 | 7 |
| Paroxysmal ventricular fibrillation | 4 | 4 | 2 |
| Sudden infant death syndrome | 4 | 4 | 4 |
| Torsades de pointes | 4 | 4 | 3 |
| Hypercapnia | 1 | 1 | 2 |
| Intellectual developmental disorder, autosomal dominant 33 | 1 | 1 | 1 |
| Neurodevelopmental disorder with cerebellar ataxia and movement disorders | 1 | 1 | 1 |
| Primary ciliary dyskinesia 5 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| SCN5A | 11 / 15 | Atrial standstill, Cardiac rhythm disease, Dilated cardiomyopathy 1E, Ectopic rhythm and 7 more |
| DPP6 | 2 / 15 | Intellectual developmental disorder, autosomal dominant 33, Paroxysmal ventricular fibrillation |
| HYDIN | 2 / 15 | Paroxysmal tachycardia, Primary ciliary dyskinesia 5 |
| KCND3 | 2 / 15 | Ectopic rhythm, Neurodevelopmental disorder with cerebellar ataxia and movement disorders |
| NPPA | 2 / 15 | Atrial standstill, Hypercapnia |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Voltage gated Potassium channels | Reactome | 2 / 43 | 31.0× | 1.85e-3 | 1.79e-2 ✓ sig. |
| Opioid Signalling | Reactome | 1 / 3 | 222× | 4.49e-3 | 3.39e-2 ✓ sig. |
| Viral myocarditis | KEGG | 2 / 70 | 19.1× | 4.82e-3 | 3.57e-2 ✓ sig. |
| Bacterial invasion of epithelial cells | KEGG | 2 / 78 | 17.1× | 5.96e-3 | 4.10e-2 ✓ sig. |
| ATP sensitive Potassium channels | Reactome | 1 / 4 | 167× | 5.98e-3 | 4.10e-2 ✓ sig. |
| CREB3 factors activate genes | Reactome | 1 / 5 | 133× | 7.47e-3 | 4.73e-2 ✓ sig. |
| NOSTRIN mediated eNOS trafficking | Reactome | 1 / 5 | 133× | 7.47e-3 | 4.73e-2 ✓ sig. |
| Biosynthesis of maresin-like SPMs | Reactome | 1 / 6 | 111× | 8.96e-3 | 5.31e-2 |
| Phase 1 - inactivation of fast Na+ channels | Reactome | 1 / 7 | 95.3× | 1.04e-2 | 5.84e-2 |
| Phase 3 - rapid repolarisation | Reactome | 1 / 8 | 83.4× | 1.19e-2 | 6.32e-2 |
| FOXO-mediated transcription of cell cycle genes | Reactome | 1 / 11 | 60.7× | 1.64e-2 | 7.63e-2 |
| Physiological factors | Reactome | 1 / 12 | 55.6× | 1.78e-2 | 8.03e-2 |
| Fluid shear stress and atherosclerosis | KEGG | 2 / 141 | 9.5× | 1.85e-2 | 8.21e-2 |
| Spinocerebellar ataxia | KEGG | 2 / 144 | 9.3× | 1.93e-2 | 8.38e-2 |
| eNOS activation | Reactome | 1 / 13 | 51.3× | 1.93e-2 | 8.40e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| regulation of heart rate by cardiac conduction | GO:0086091 | 5 / 43 | 121× | 4.25e-10 | 1.11e-7 ✓ sig. |
| ventricular cardiac muscle cell action potential | GO:0086005 | 4 / 17 | 244× | 1.42e-9 | 3.17e-7 ✓ sig. |
| regulation of ventricular cardiac muscle cell membrane repolarization | GO:0060307 | 4 / 21 | 198× | 3.57e-9 | 7.11e-7 ✓ sig. |
| regulation of ventricular cardiac muscle cell membrane depolarization | GO:0060373 | 3 / 7 | 445× | 2.62e-8 | 4.09e-6 ✓ sig. |
| negative regulation of potassium ion transmembrane transport | GO:1901380 | 3 / 13 | 240× | 2.13e-7 | 2.38e-5 ✓ sig. |
| membrane repolarization during ventricular cardiac muscle cell action potential | GO:0098915 | 3 / 13 | 240× | 2.13e-7 | 2.38e-5 ✓ sig. |
| cardiac conduction system development | GO:0003161 | 3 / 16 | 195× | 4.17e-7 | 4.18e-5 ✓ sig. |
| regulation of cardiac muscle contraction | GO:0055117 | 3 / 24 | 130× | 1.50e-6 | 1.20e-4 ✓ sig. |
| AV node cell to bundle of His cell communication | GO:0086067 | 2 / 3 | 692× | 2.63e-6 | 1.89e-4 ✓ sig. |
| regulation of membrane depolarization during cardiac muscle cell action potential | GO:1900825 | 2 / 4 | 519× | 5.25e-6 | 3.29e-4 ✓ sig. |
| regulation of heart rate | GO:0002027 | 3 / 39 | 79.9× | 6.71e-6 | 3.99e-4 ✓ sig. |
| potassium ion transport | GO:0006813 | 4 / 152 | 27.3× | 1.18e-5 | 6.16e-4 ✓ sig. |
| regulation of atrial cardiac muscle cell membrane repolarization | GO:0060372 | 2 / 6 | 346× | 1.31e-5 | 6.71e-4 ✓ sig. |
| SA node cell action potential | GO:0086015 | 2 / 6 | 346× | 1.31e-5 | 6.71e-4 ✓ sig. |
| vasodilation | GO:0042311 | 3 / 50 | 62.3× | 1.43e-5 | 7.18e-4 ✓ sig. |